Fundraising Fox
🦊/People
Sign in

Yvonne Yamanaka

Investor

Principal at venBio Partners

San Francisco, California

Writes $20M – $30M checks · typically $25M

Find your path to Yvonne

622 people in our graph share verified history with Yvonne — schools, employers, funds. One of them is your warm intro.

Noubar AfeyanunlockedYvonne: together at Flagship Pioneering (2014–2016)
×4Yvonne: together at Duke University
×2Yvonne: together at Massachusetts Institute of Technology (MIT)
×4Yvonne: together at Flagship Pioneering

About

Yvonne Yamanaka combines hands-on technical experience—she helped invent an immunotherapy platform as a graduate student and led its development at EMD/Merck Serono—and built companies from the whiteboard up at Flagship Pioneering.

Invests in

BiotechHealthtech

Experience

  1. venBio PartnersPartnercurrent2016 — presentSan Francisco Bay Area
  2. Flagship PioneeringAssociate2015 — 2016
  3. EMD Serono, Inc.Postdoctoral Fellow, Immuno-Oncology & Immuno-Technologies2014 — 2015
  4. Flagship PioneeringVentureLabs Fellow2014
  5. Massachusetts Institute of Technology (MIT)Ph.D., Biological Engineering2008 — 2014
  6. American Journal ExpertsContract Editor2012 — 2013

Investments

Investor

Abdera TherapeuticsArtiva BiotherapeuticsImmPACT Bio

Per curated public sources.

Colleagues at venBio Partners

Aaron Royston
Managing Partner at venBio Partners
Behzad Aghazadeh
Executive Officer at venBio Partners
Corey Goodman
Co-founder and Managing Partner at venBio Partners
Daniel Teichmann
Controller at venBio Partners
David Pezeshki
Chief Financial Officer at venBio Partners
Jaume Pons
Venture Partner at venBio Partners
Neil Cammarosano
Executive Officer at venBio Partners
Parthiv Patel
Analyst at venBio Partners

Network2

Aaron Royston
Managing Partner at venBio Partners
Corey Goodman
Co-founder and Managing Partner at venBio Partners

Investors connected to Yvonne in public investor directories — a warm-intro map.

Frequently asked questions

Who is Yvonne Yamanaka?
Yvonne Yamanaka combines hands-on technical experience—she helped invent an immunotherapy platform as a graduate student and led its development at EMD/Merck Serono—and built companies from the whiteboard up at Flagship Pioneering.
Where does Yvonne Yamanaka work?
Yvonne Yamanaka is Principal at venBio Partners.
What does Yvonne Yamanaka invest in?
Yvonne Yamanaka invests in Biotech, Healthtech.
What check size does Yvonne Yamanaka write?
Yvonne Yamanaka typically writes checks of $20M – $30M.
What companies has Yvonne Yamanaka invested in?
Investments tracked here include Abdera Therapeutics, Artiva Biotherapeutics, ImmPACT Bio.
Where did Yvonne Yamanaka go to school?
Yvonne Yamanaka studied at Massachusetts Institute of Technology (Doctor of Philosophy (Ph.D.), Biological Engineering); Duke University (B.S.E., Biomedical Engineering).

Same school

Shared employers